RXRA and type 2 diabetes mellitus: Specifically, the elevated expression of ANPEP, BECN1, HNF1A, and ST6GAL1 was associated with an increased risk of T2D, while the expression of PGF, RXRA, SREBF1, and USP7 decreased the risk of T2D.